|
|
Post by cgiscgis on Oct 31, 2016 11:50:48 GMT -5
There are 1,113 Afrezza doctors across USA.
If we consider the weekly script count this represents a rather appalling performance.
Is it too much to expect 1 prescription per doctor per week?
Something is not adding up here!?
STATE COUNT
AL 9
AK 4
AZ 21
AR 2
CA 145
CO 12
CT 16
DE 5
DC 5
FL 52
GA 33
HI 14
ID 6
IL 37
IN 32
IA 8
KS 11
KY 19
LA 14
ME 3
MD 19
MA 21
MI 28
MN 5
MS 12
MO 32
MT 3
NE 7
NV 6
NH 5
NJ 44
NM 4
NY 101
NC 45
ND 1
OH 41
OK 8
OR 11
PA 37
RI 2
SC 25
SD 2
TN 28
TX 91
UT 7
VT 1
VA 22
WA 37
WV 9
WI 8
WY 3
Total: 1113
|
|
|
|
Post by mannmade on Oct 31, 2016 12:15:45 GMT -5
Well I would have to agree. I have not checked the list for the specific name of one endo I know (that I am meeting with the first week in Dec) but he has 1 patient on AFREZZA who only uses it for corrections. So if he is on the list it might explain some of the fuzzy math here...
|
|
|
|
Post by boomboom on Oct 31, 2016 12:20:34 GMT -5
You are assuming these doctors are advocates. I imagine this list was compiled by surveying doctors and asking the question "would you be willing to prescribe Afrezza?" IMO, most doctors would answer "yes, of course I would be willing" and Boom! your name is on the list. Does not mean they have an understanding of the full potential of the drug and are fighting to convert all of their patients as soon as possible.
|
|
|
|
Post by mannmade on Oct 31, 2016 12:22:24 GMT -5
Could also be the concern that MannKind may not be around much longer. Who knows what the other drug reps are telling the docs.
|
|
|
|
Post by cgiscgis on Oct 31, 2016 12:22:58 GMT -5
|
|
|
|
Post by esstan2001 on Oct 31, 2016 12:26:41 GMT -5
You are assuming these doctors are advocates. I imagine this list was compiled by surveying doctors and asking the question "would you be willing to prescribe Afrezza?" IMO, most doctors would answer "yes, of course I would be willing" and Boom! your name is on the list. Does not mean they have an understanding of the full potential of the drug and are fighting to convert all of their patients as soon as possible. Docs are getting detailed thru dinner meetings, clinic visits by Mike with user patients, and NP trainer visits. IMO the list should be and most probably is representative of this group. |
|
|
|
Post by boomboom on Oct 31, 2016 12:30:59 GMT -5
The source is not the issue. My point is that Mannkind needs to know who is not going to shut the door on a patient who requests Afrezza because its a new technology/drug. So the list, though compiled by Mannkind, does not necessarily mean that these doctors are excited and out searching for patients. They are only there to accommodate a patient that either 1) requests it on their own and agrees it is a good fit or 2) will benefit from an inhaled option
I would include a #3 that says "would benefit from superior control of prandial glucose spikes" but I do not believe most doctors believe Afrezza is the real deal yet. Hence, this option 3 will come at a later time when Afrezza proves it deserves a seat in the prandial market
|
|
